Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Download (PDF, 222KB)
December 3, 2019
/
Guidelines
,
News
Share
the Post
Related
Posts
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Asia Pacific Situational Updates on Generic DAAs – June 2017
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
New WHO guideline on care and treatment of chronic hepatitis C
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
